# Title
Quantification O
of O
carnitine B-Chemical
and O
specific O
acylcarnitines B-Chemical
by O
high-performance O
liquid O
chromatography: O
application O
to O
normal O
human B-Species
urine O
and O
urine O
from O
patients B-Species
with O
methylmalonic B-Disease
aciduria, I-Disease
isovaleric B-Disease
acidemia I-Disease
or O
medium-chain B-Disease
acyl-CoA I-Disease
dehydrogenase I-Disease
deficiency. I-Disease

# Abstract
This O
paper O
describes O
the O
development O
of O
a O
high-performance O
liquid O
chromatographic O
method O
for O
the O
quantitation O
of O
free O
carnitine, B-Chemical
total O
carnitine, B-Chemical
acetylcarnitine, B-Chemical
propionylcarnitine, B-Chemical
isovalerylcarnitine, B-Chemical
hexanoylcarnitine B-Chemical
and O
octanoylcarnitine B-Chemical
in O
human B-Species
urine. O
Carnitine B-Chemical
and O
acylcarnitines B-Chemical
were O
isolated O
from O
10 O
or O
25 O
microliters O
of O
urine O
using O
0.5-ml O
columns O
of O
silica B-Chemical
gel, I-Chemical
derivatized O
with O
4'-bromophenacyl B-Chemical
trifluoromethanesulfonate I-Chemical
and O
separated O
by O
high-performance O
liquid O
chromatography. O
Using O
4-(N,N-dimethyl-N-ethylammonio)-3-hydroxybutanoate B-Chemical
("e-carnitine") B-Chemical
as O
the O
internal O
standard, O
standard O
curves O
(10-300 O
nmol O
ml) O
were O
generated. O
Carnitine B-Chemical
and O
acylcarnitines B-Chemical
were O
quantified O
(when O
they O
were O
present) O
in O
normal O
human B-Species
urine O
and O
the O
urine O
of O
patients B-Species
diagnosed O
with O
one O
of O
three O
different O
disorders O
of O
organic B-Disease
acid I-Disease
metabolism: I-Disease
methylmalonic B-Disease
aciduria, I-Disease
isovaleric B-Disease
aciduria, I-Disease
isovaleric B-Disease
acidemia, I-Disease
and O
medium-chain B-Disease
acyl-CoA I-Disease
dehydrogenase I-Disease
deficiency. I-Disease